Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Cash Flow Quality Index
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Cash Flow Quality Index of -4.05x as of March 2025. Operating cash flow of CN¥-98.63 Million is below net income of CN¥24.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Hainan Huluwa Pharmaceutical Group Co Lt asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hainan Huluwa Pharmaceutical Group Co Ltd Cash Flow Quality Index (2016–2023)
Historical Cash Flow Quality Index for Hainan Huluwa Pharmaceutical Group Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hainan Huluwa Pharmaceutical Group Co Lt tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2023)
Year-by-year earnings quality comparison for Hainan Huluwa Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see Hainan Huluwa Pharmaceutical Group Co Lt (605199) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.27x | CN¥28.25 Million | CN¥106.50 Million | ▼ -90.6% |
| 2022 | 2.82x | CN¥238.71 Million | CN¥84.74 Million | ▲ +91.2% |
| 2021 | 1.47x | CN¥102.48 Million | CN¥69.56 Million | ▲ +5325.1% |
| 2020 | 0.03x | CN¥3.30 Million | CN¥121.50 Million | ▼ -97.7% |
| 2019 | 1.20x | CN¥144.51 Million | CN¥120.33 Million | ▲ +279.7% |
| 2018 | 0.32x | CN¥31.80 Million | CN¥100.54 Million | ▼ -92.2% |
| 2017 | 4.07x | CN¥89.96 Million | CN¥22.13 Million | ▲ +111.3% |
| 2016 | 1.92x | CN¥64.96 Million | CN¥33.76 Million | — |